Altimmune shares are trading lower after Kerrisdale Capital issued a short report on the stock.
Portfolio Pulse from Benzinga Newsdesk
Altimmune shares are trading lower following a short report issued by Kerrisdale Capital.
February 13, 2024 | 4:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Altimmune's stock price is experiencing a downturn as a result of a negative report by Kerrisdale Capital.
Kerrisdale Capital, known for its influential reports, has issued a short report on Altimmune, leading to a decrease in the stock's price. Given Kerrisdale's reputation, its negative outlook likely swayed investor sentiment, causing a sell-off.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100